Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Related and Unrelated Donor Hematopoietic Stem Cell Transplant for DOCK8 Deficiency

NCT01176006 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01176006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01176006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Related and Unrelated Donor Hematopoietic Stem Cell Transplant for DOCK8 Deficiency
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Active, not recruiting
Start date
October 5, 2010
Completion date
October 31, 2028
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dock8 deficiency